论文信息 - 1 Extended adjuvant therapy with neratinib plus fulvestrant blocks ER/HER2 crosstalk and 1 maintains complete responses of ER+/HER2+ breast cancers: Implications to the ExteNET 2 trial 3 - 字舞流文

1 Extended adjuvant therapy with neratinib plus fulvestrant blocks ER/HER2 crosstalk and 1 maintains complete responses of ER+/HER2+ breast cancers: Implications to the ExteNET 2 trial 3

Balko | A. Guerrero-Zotano | M. Sanders | C. Arteaga | L. Formisano | A. Lalani | R. Cutler | L. Schwarz | Dhivya R. Sudhan | Nixon | P. G. Ericsson | Sarah Croessmann | Richard | Francesca Avogadri-Connors | A. Auerbach | Mellissa | Bryce | D. Sudhan